Pfizer's Stock Sees Decline, Underperforms Sector by -2.73%

Pfizer ., a leading pharmaceutical and drug company, has recently seen a decline in its stock performance. On September 30th, 2024, the company's stock lost -3.63%, underperforming the sector by -2.73%. This has led to a 'Hold' call by MarketsMOJO for Pfizer's stock.

The stock's price summary for the day shows that it touched an intraday low of Rs 5622.6, a decrease of -3.32%. However, the moving averages for Pfizer's stock are still higher than the 5 day, 100 day, and 200 day moving averages. It is worth noting that the stock is currently lower than the 20 day and 50 day moving averages.

In comparison to the overall market performance, Pfizer's stock has underperformed. On the same day, the stock's performance was -3.76% while the Sensex's performance was -0.76%. Over the past month, Pfizer's stock has also seen a decline of -7.27%, while the Sensex has seen a positive performance of 3.11%.

Despite the recent decline in stock performance, Pfizer remains a largecap company in the pharmaceutical and drug industry. As a neutral and informative news article, it is important to note that this article does not mention any future potential, investor interest, or expert opinions. The information provided is based on facts and data from the company's stock performance.